The immunological mechanism of PGRNs anti-inflammatory effect - Renewal - 1
The immunological mechanism of PGRNs anti-inflammatory effect - Renewal - 1
批准号:
10431930
负责人:
Chuanju Liu
金额:
$53.16万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-09-01 至 2024-06-30
关键词:
AffinityAnkylosing spondylitisAnti-Inflammatory AgentsAntiinflammatory EffectAttentionBindingBiochemicalChronic small plaque psoriasisCollagen ArthritisComplement 5aComplexCrohn&aposs diseaseDependenceDevelopmentDiseaseDoseExhibitsFundingGenesGrowth FactorImmune responseImmunologicsInfectionInflammationInflammatoryInflammatory ArthritisInflammatory Bowel DiseasesInterventionKnock-outLaboratoriesLeadLigandsMass Spectrum AnalysisMediatingModelingMusPGRN genePathogenesisPathway interactionsPatientsPeptide FragmentsPhenotypePlayPositioning AttributeProcessProgress ReportsPropertyProteomicsPsoriatic ArthritisPublicationsRecombinantsRegulationRegulatory T-LymphocyteResearchRoleScienceSeriesSignal PathwaySignal TransductionSignaling MoleculeSystemic Lupus ErythematosusTNF geneTNFRSF1A geneTNFRSF1B geneTestingTherapeuticTransgenic OrganismsTumor Necrosis Factor ReceptorUlcerative Colitisantagonistbasebone erosioncancer riskchronic inflammatory diseaseclinical practicecomplement systemeffective therapyinhibitormacrophagemembernovelnovel therapeutic interventionpreventprogramsprotein protein interactionreceptorreceptor bindingrecruitresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Description
TNFα/TNFR has received the greatest attention because of its position at the apex of the pro-inflammatory cy-
tokine cascade, and its dominance in the pathogenesis of inflammation. TNFR1 primarily mediates inflammato-
ry activity of TNFα, whereas TNFR2 plays a protective and anti-inflammatory role in various diseases. Our ge-
netic screen for the binding partners of progranulin (PGRN) growth factor led to the isolation of TNFR2 as the
PGRN-binding receptor (Tang, et al, Science, 2011). Remarkably, PGRN exhibits an approximately 600-fold
higher binding affinity to TNFR2 than does TNFα. During the initial funding period, we have successfully identi-
fied in a proteomics screen 14-3-3ε, an important intracellular signaling molecule, as a novel component of
TNFR2 complexes in response to PGRN stimulation. PGRN deficiency promoted inflammatory classically-
activated macrophage (CAM) but inhibited anti-inflammatory alternatively-activated macrophage (AAM) polari-
zation, whereas recombinant PGRN inhibited AAM-CAM but stimulated CAM-AAM switching. In addition,
knockout of 14-3-3ε abolished PGRN’s regulation of macrophage. More excitingly, our direct protein-protein
interaction screen of nine central members of the complement system identified C5a as a novel binding partner
of PGRN with high binding affinity, and PGRN inhibited the binding of C5a to C5aR1. Thus, the scientific prem-
ise of this competitive continued application is based on 1) the identification of 14-3-3ε as a novel component
of PGRN/TNFR2 pathway, and 2) the isolation of C5a as a novel PGRN-binding factor. The central hypothesis
is that PGRN regulates macrophage polarization and inflammatory arthritis through a) recruitment of 14-3-3ε to
TNFR2 and activation of the PGRN/TNFR2 anti-inflammatory pathway; and b) interplay with C5a and inhibition
of C5a/C5aR1 inflammatory pathway. The Specific Aims are: (1) To elucidate 14-3-3ε’s role in PGRN/TNFR2-
mediated macrophage polarization in the course of inflammatory arthritis. We will determine the dependence
on 14-3-3ε of PGRN's regulation of macrophage polarization (SA#1.1); the signaling, target genes and co-
factor(s) of 14-3-3ε that mediate PGRN action in macrophage polarization (SA#1.2); and the importance of
PGRN regulation of macrophage phenotypic switch in the context of inflammatory arthritis and its dependence
on 14-3-3ε (SA#1.3). (2) To define the importance of PGRN/C5a interplay in the pathogenesis of inflammatory
arthritis. We will characterize and dissect the PGRN/C5a interaction and to identify PGRN-derived minimal
fragment/peptide that retains C5a binding activity (SA#2.1); elucidate the interplay between PGRN and C5a in
regulating macrophage polarization, as well as the signaling pathways involved (SA#2.2); and determine the
interplay between PGRN and C5a/C5aR1 signaling and the contribution of inhibition of C5a/C5aR1 signaling
by PGRN to PGRN's anti-inflammatory action in inflammatory arthritis (SA#2.3). The proposed research will
not only advance our understanding of the pathogenesis of inflammatory arthritis, but may also lead to the de-
velopment of new interventions for various TNFR- and C5a/C5aR1-related conditions and diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting TNF Receptors to Inhibit Inflammation and to Prompt Bone Regeneration in Type 1 Diabetes
-
批准号:10915157
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2023
-
负责人:Chuanju Liu
-
依托单位:
The immunological mechanism of PGRNs anti-inflammatory effect
-
批准号:10912299
-
项目类别:
-
资助金额:$53.06万
-
财政年份:2023
-
负责人:Chuanju Liu
-
依托单位:
The Role of Sodium Channel Nav1.7 in Osteoarthritis - Resubmission - 1
-
批准号:10390155
-
项目类别:
-
资助金额:$69.54万
-
财政年份:2022
-
负责人:Chuanju Liu
-
依托单位:
A new mouse model to study GBA1 mutation-associated diseases with multiple organs involvement
-
批准号:10651885
-
项目类别:
-
资助金额:$20.31万
-
财政年份:2022
-
负责人:Chuanju Liu
-
依托单位:
A new mouse model to study GBA1 mutation-associated diseases with multiple organs involvement
-
批准号:10508985
-
项目类别:
-
资助金额:$25.85万
-
财政年份:2022
-
负责人:Chuanju Liu
-
依托单位:
Targeting TNF Receptors to Inhibit Inflammation and to Prompt Bone Regeneration in Type 1 Diabetes - Resubmission - 1
-
批准号:10453563
-
项目类别:
-
资助金额:$40.08万
-
财政年份:2020
-
负责人:Chuanju Liu
-
依托单位:
Targeting TNF Receptors to Inhibit Inflammation and to Prompt Bone Regeneration in Type 1 Diabetes - Resubmission - 1
-
批准号:10218061
-
项目类别:
-
资助金额:$39.27万
-
财政年份:2020
-
负责人:Chuanju Liu
-
依托单位:
Progranulin: A Novel Gene in Gaucher Diseases
-
批准号:10251862
-
项目类别:
-
资助金额:$47.91万
-
财政年份:2017
-
负责人:Chuanju Liu
-
依托单位:
Progranulin: A Novel Gene in Gaucher Diseases
-
批准号:10011889
-
项目类别:
-
资助金额:$47.91万
-
财政年份:2017
-
负责人:Chuanju Liu
-
依托单位:
Progranulin Intervention in Inflammatory Bowel Diseases
-
批准号:8708276
-
项目类别:
-
资助金额:$21.19万
-
财政年份:2013
-
负责人:Chuanju Liu
-
依托单位:
The Role of PGRN Growth Factor in Osteoarthritis
-
批准号:8698896
-
项目类别:
-
资助金额:$47.49万
-
财政年份:2013
-
负责人:Chuanju Liu
-
依托单位:
The immunological mechanism of PGRNs anti-inflammatory effect
-
批准号:8698895
-
项目类别:
-
资助金额:$38.03万
-
财政年份:2013
-
负责人:Chuanju Liu
-
依托单位:
The immunological mechanism of PGRNs anti-inflammatory effect
-
批准号:8371576
-
项目类别:
-
资助金额:$38.03万
-
财政年份:2012
-
负责人:Chuanju Liu
-
依托单位:
The immunological mechanism of PGRNs anti-inflammatory effect
-
批准号:8509606
-
项目类别:
-
资助金额:$36.12万
-
财政年份:2012
-
负责人:Chuanju Liu
-
依托单位:
The immunological mechanism of PGRNs anti-inflammatory effect
-
批准号:8663197
-
项目类别:
-
资助金额:$37.26万
-
财政年份:2012
-
负责人:Chuanju Liu
-
依托单位:
Progranulin Intervention in Inflammatory Bowel Diseases
-
批准号:8534426
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2012
-
负责人:Chuanju Liu
-
依托单位:
The immunological mechanism of PGRNs anti-inflammatory effect - Renewal - 1
-
批准号:10198768
-
项目类别:
-
资助金额:$52.08万
-
财政年份:2012
-
负责人:Chuanju Liu
-
依托单位:
The Role of PGRN Growth Factor in Osteoarthritis
-
批准号:8162691
-
项目类别:
-
资助金额:$38.03万
-
财政年份:2011
-
负责人:Chuanju Liu
-
依托单位:
The Role of PGRN Growth Factor in Osteoarthritis
-
批准号:8707378
-
项目类别:
-
资助金额:$37.26万
-
财政年份:2011
-
负责人:Chuanju Liu
-
依托单位:
The Role of PGRN Growth Factor in Osteoarthritis. - Renewal - 1
-
批准号:9441625
-
项目类别:
-
资助金额:$25.43万
-
财政年份:2011
-
负责人:Chuanju Liu
-
依托单位:
海外基金